A sample size adjustment procedure for clinical trials based on conditional power.
about
Two-stage adaptive design for clinical trials with survival dataSample size re-estimation for survival data in clinical trials with an adaptive design.Choosing inclusion criteria that minimize the time and cost of clinical trialsRandomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialAdaptive trial designs.Cognition in movement disorders: where can we hope to be in ten years?Adaptive statistical analysis following sample size modification based on interim review of effect size.Sequential biases in accumulating evidence.A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.Rate of decline in progressive supranuclear palsy.Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.Minimizing the maximum expected sample size in two-stage Phase II clinical trials with continuous outcomes.Unbiased estimation for response adaptive clinical trials.Increasing the sample size at interim for a two-sample experiment without Type I error inflation.An adaptive group sequential phase II design to compare treatments for survival endpoints in rare patient entities.Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.Statistical inference following sample size adjustment based on the 50%-conditional-power principle.On efficient two-stage adaptive designs for clinical trials with sample size adjustment.A model-based conditional power assessment for decision making in randomized controlled trial studies.Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.Blinded assessment of treatment effects for survival endpoint in an ongoing trial.An extension of Bayesian expected power and its application in decision making.Point and interval estimation of primary and secondary parameters in a two-stage adaptive clinical trial.
P2860
Q28184107-81279D60-A269-4C06-851A-0F7C7B16156CQ34157072-FC871A3B-DCB9-487E-8718-5AA89B3DB029Q34367570-805F4BB3-10C8-4EEB-A53E-640B08266F97Q34440571-918CEE02-2B04-4BD9-ADE4-BF4292A077D1Q34486230-1C672088-6503-461B-8D9D-6E3FD3B5FDF9Q34977626-8D78DC1B-BC3D-4D24-AA5D-00BED5466167Q35211553-17768E92-1F7C-4E1A-B78C-5512CCC5560DQ36196222-526A5784-BF64-4B51-B1E0-84842027E148Q37272552-DC5ED061-5163-464B-979F-9DE5D43C4774Q38201406-0AC176AC-9127-4010-9B7C-4CBC9A866DDDQ39234422-4775DE3B-8A18-4C24-81E7-7B1691C00A1CQ40714213-4F38785B-8DA0-4EE0-B96C-F2A92B3FC5A1Q40961219-B53098CE-9991-4CA9-94D1-062EE51C753FQ41490570-240B07BF-0CD9-407A-BC59-4FEE844AFFB8Q43405141-0FA7CCED-8C11-4CE5-A80F-EDBF20819EA3Q43498261-63935E9E-7E56-43EF-83DB-98BAB517EFD0Q45194501-D6ACD8BB-7613-4D39-9442-450CE84148B7Q47191517-4F7956EE-71E5-4F5B-95EE-7AD8AD5B84B9Q47306607-4A6DD1BB-120F-46B8-AE82-3B60544F8922Q48134852-766E11DD-9516-4BF3-BBD9-6CD880C97B70Q51397243-E0A07929-5807-462D-9B41-A5734AFDD356Q51422622-E25A5DDA-4CE1-4FA4-83C6-F1F5E0CD7729Q51611524-3BB45840-4DD4-456D-BB67-005AD5E3CEBCQ51891392-1B06EED7-9E09-4386-A88D-FFCB1EF01A17
P2860
A sample size adjustment procedure for clinical trials based on conditional power.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A sample size adjustment procedure for clinical trials based on conditional power.
@en
A sample size adjustment procedure for clinical trials based on conditional power.
@nl
type
label
A sample size adjustment procedure for clinical trials based on conditional power.
@en
A sample size adjustment procedure for clinical trials based on conditional power.
@nl
prefLabel
A sample size adjustment procedure for clinical trials based on conditional power.
@en
A sample size adjustment procedure for clinical trials based on conditional power.
@nl
P2093
P356
P1433
P1476
A sample size adjustment procedure for clinical trials based on conditional power.
@en
P2093
Tailiang Xie
Weichung J Shih
P304
P356
10.1093/BIOSTATISTICS/3.2.277
P577
2002-06-01T00:00:00Z